The role of c-Jun N-terminal kinase (JNK) in Parkinson's disease

IUBMB Life

Volumn 55, Issue 4-5, 2003, Pages 267-271

  Peng, Jun ^a   Andersen, Julie K ^a  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

c Jun amino terminal kinases; Dopamine; MPTP; Neuronal death; Parkinson's disease

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA SYNUCLEIN; AMINO ACID; AMYLOID BETA PROTEIN; CYTOKINE; DIELDRIN; DOPAMINE; MANEB; MANGANESE; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; NEUROTOXIN; PARAQUAT; PHOSPHOTRANSFERASE; PROTEIN FOS; REACTIVE OXYGEN METABOLITE; ROTENONE; SALSOLINOL; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

CELL ACTIVITY; CELL LOSS; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; ENZYME ACTIVATION; ENZYME INACTIVATION; HUMAN; LEWY BODY; NERVE CELL NECROSIS; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; PARKINSON DISEASE; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0038152778     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/1521654031000121666     Document Type: Review

References (44)

1. Lang, A. E., and Lozano, A. M. (1998) Parkinson's disease. First of two parts. N. Engl. J. Med. 339, 1044-1053.
2. Forno, L. S. (1996) Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 55, 259-272.
3. Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J. T., Schols, L., and Riess, O. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18, 106-108.
4. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E. S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. G., Lazzarini, A. M., Duvoisin, R. C., Di Iorio, G., Golbe, L. I., and Nussbaum, R. L. (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.
5. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., and Shimizu, N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608.
6. Menegon, A., Board, P. G., Blackburn, A. C., Mellick, G. D., and Le Couteur, D. G. (1998) Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet 352, 1344-1346.
7. Butterfield, P. G., Valanis, B. G., Spencer, P. S., Lindeman, C. A., and Nutt, J. G. (1993) Environmental antecedents of young-onset Parkinson's disease. Neurology 43, 1150-1158.
8. Gorell, J. M., Johnson, C. C., Rybicki, B. A., Peterson, E. L., and Richardson, R. J. (1998) The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology 50, 1346-1350.
9. Johnson, G. L., and Lapadat, R. (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912.
10. Gallo, K. A., and Johnson, G. L. (2002) Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat. Rev. Mol. Cell Biol. 3, 663-672.
11. Kyriakis, J. M., and Avruch, J. (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81, 807-869.
12. Keyse, S. M. (2000) Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12, 186-192.
13. Davis, R. J. (2000) Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
14. Meyer, D., Liu, A., and Margolis, B. (1999) Interaction of c-Jun amino-terminal kinase interacting protein-1 with p190 rhoGEF and its localization in differentiated neurons. J. Biol. Chem. 274, 35113-35118.
15. Whitmarsh, A. J., Cavanagh, J., Tournier, C., Yasuda, J., and Davis, R. J. (1998) A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 281, 1671-1674.
16. Kanamoto, T., Mota, M., Takeda, K., Rubin, L. L., Miyazono, K., Ichijo, H., and Bazenet, C. E. (2000) Role of apoptosis signal-regulating kinase in regulation of the c-Jun N-terminal kinase pathway and apoptosis in sympathetic neurons. Mol. Cell Biol. 20, 196-204.
17. Esler, W. P., and Wolfe, M. S. (2001) A portrait of Alzheimer secretases-new features and familiar faces. Science 293, 1449-1454.
18. Wei, W., Norton, D. D., Wang, X., and Kusiak, J. W. (2002) Aβ 17-42 in Alzheimer's disease activates JNK and caspase-8 leading to neuronal apoptosis. Brain 125, 2036-2043.
19. Yang, D. D., Kuan, C. Y., Whitmarsh, A. J., Rincon, M., Zheng, T. S., Davis, R. J., Rakic, P., and Flavell, R. A. (1997) Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389, 865-870.
20. Kuan, C. Y., Yang, D. D., Samanta Roy, D. R., Davis, R. J., Rakic, P., and Flavell, R. A. (1999) The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22, 667-676.
21. Bharath, S., Hsu, M., Kaur, D., Rajagopalan, S., and Andersen, J. K. (2002) Glutathione, iron and Parkinson's disease. Biochem. Pharmacol. 64, 1037-1048.
22. Przedborski, S., and Jackson-Lewis, V. (1998) Mechanisms of MPTP toxicity. Mov. Disord. 13, 35-38.
23. + opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim. Biophys. Acta 1453, 49-62.
24. 2-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo. J. Neurochem. 75, 1200-1208.
25. Xia, X. G., Harding, T., Weller, M., Bieneman, A., Uney, J. B., and Schulz, J. B. (2001) Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease. Proc. Natl. Acad. Sci. USA 98, 10433-10438.
26. Willesen, M. G., Gammeltoft, S., and Vaudano, E. (2002) Activation of the c-Jun N terminal kinase pathway in an animal model of Parkinson's disease. Ann. NY Acad. Sci. 973, 237-240.
27. Trimmer, P. A., Smith, T. S., Jung, A. B., and Bennett, J.P. Jr. (1996) Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity. Neurodegeneration 5, 233-239.
28. Seidler, A., Hellenbrand, W., Robra, B. P., Vieregge, P., Nischan, P., Joerg, J., Oertel, W. H., Ulm, G., and Schneider, E. (1996) Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology 46, 1275-1284.
29. Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R., and Langston, J. W. (1999) Parkinson disease in twins: an etiologic study. JAMA 281, 341-346.
30. +, oxidant and specific neurotoxicants shares the common molecular mechanism. J. Neurochem. 76, 1010-1021.
31. Maroney, A. C., Finn, J. P., Bozyczko-Coyne, D., O'Kane, T. M., Neff, N. T., Tolkovsky, A. M., Park, D. S., Yan, C. Y., Troy, C. M., and Greene, L. A. (1999) CEP-1347 (KT7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults. J. Neurochem. 73, 1901-1912.
32. Hirata, Y., Adachi, K., and Kiuchi, K. (1998) Activation of JNK pathway and induction of apoptosis by manganese in PC12 cells. J. Neurochem. 71, 1607-1615.
33. Luo, Y., Umegaki, H., Wang, X., Abe, R., and Roth, G. S. (1998) Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway. J. Biol. Chem. 273, 3756-3764.
34. Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R., and Goedert, M. (1997) Alpha-synuclein in Lewy bodies. Nature 388, 839-840.
35. Gosavi, N., Lee, H. J., Lee, J. S., Patel, S., and Lee, S. J. (2002) Golgi fragmentation occurs in the cells with prefibrillar α-synuclein aggregates and precedes the formation of fibrillar inclusion. J. Biol. Chem. 277, 48984-48992.
36. Lee, M., Hyun, D., Halliwell, B., and Jenner, P. (2001) Effect of the overexpression of wild-type or mutant α-synuclein on cell susceptibility to insult. J. Neurochem. 76, 998-1009.
37. Hashimoto, M., Hsu, L. J., Rockenstein, E., Takenouchi, T., Mallory, M., and Masliah, E. (2002) α-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells. J. Biol. Chem. 277, 11465-11472.
38. Maroney, A. C., Glicksman, M. A., Basma, A. N., Walton, K. M., Knight, Jr., E., Murphy, C. A., Bartlett, B. A., Finn, J. P., Angeles, T., Matsuda, Y., Neff, N. T., and Dionne, C. A. (1998) Motoneuron apoptosis is blocked by CEP- 1347 (KT 7515), a novel inhibitor of the JNK signaling pathway. J. Neurosci. 18, 104-111.
39. Saporito, M. S., Brown, E. M., Miller, M. S., and Carswell, S. (1999) CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo. J. Pharmacol. Exp. Ther. 288, 421-427.
40. Saporito, M. S., Hudkins, R. L., and Maroney, A. C. (2002) Discovery of CEP-1347/KT-7515, an inhibitor of the JNK/SAPK pathway for the treatment of neurodegenerative diseases. Prog. Med. Chem. 40, 23-62.
41. Hertzman, C., Wiens, M., Bowering, D., Snow, B., and Calne, D. (1990) Parkinson's disease: a case-control study of occupational and environmental risk factors. Am. J. Ind. Med. 17, 349-355.
42. Liou, H. H., Tsai, M. C., Chen, C. J., Jeng, J. S., Chang, Y. C., Chen, S. Y., and Chen, R. C. (1997) Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 48, 1583-1588.
43. Thiruchelvam, M., Richfield, E. K., Baggs, R. B., Tank, A. W., and Cory-Slechta, D. A. (2000) The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. J. Neurosci. 20, 9207-9214.
44. Xu, Y. H., Brown-Jermyn, D. J., Bastia, E., Wang, X., Chen, J. F., and Schwarzschild, M. A. (2002) Locomotor decline in the a chronic pesticide model of Parkinson's disease is attenuated in mice lacking JNK3. Abst. Soc. Neurosci. 691.1.